查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048144

新興心理健康設備和平台市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Emerging Mental Health Devices and Platforms Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球新興心理健康設備和平台市場預計將從 2025 年的 43.7 億美元大幅成長至 2031 年的 126.7 億美元，複合年成長率為 19.41%。

該領域涵蓋了廣泛的創新，包括數位療法、用於生物特徵追蹤的穿戴式感測器以及旨在提供遠端心理支持和持續評估的人工智慧遠距精神科諮詢軟體。推動市場成長的關鍵因素是全球精神疾病盛行率的上升以及合格精神衛生專業人員的嚴重短缺，這共同催生了對可擴展數位干預措施的需求，以填補現有醫療服務的空白。此外，監管機構對遠端患者監護的支持力度不斷加大，以及醫療模式向以價值為導向、優先考慮可及性和早期療育而非傳統面對面治療的模式轉變，也進一步促進了這些因素的發展。然而，該市場面臨許多挑戰，主要包括資料隱私問題以及醫療設備軟體複雜的法律制度，這些都可能阻礙產品的上市。嚴格的患者資料安全合規要求對希望進入該市場的新開發人員構成了重大障礙。根據世界衛生組織 (WHO) 的報告，到 2025 年，遠距心理健康服務將擴展到全球 60% 以上的國家，這凸顯了服務提供者除了要應對這些複雜的監管挑戰之外，還必須應對重大的基礎設施變革。

市場概覽
預測期 2027-2031
市場規模：2025年 43.7億美元
市場規模：2031年 126.7億美元
複合年成長率：2026-2031年 19.41%
成長最快的細分市場 焦慮
最大的市場 北美洲

市場促進因素

全球精神疾病盛行率的不斷上升是推動市場發展的主要動力，也因此迫切需要擴充性且易於取得的治療性介入，而傳統的面對面診療模式無法充分滿足這些需求。隨著焦慮症和憂鬱症病例的增加，醫療保健系統正擴大採用數位化平台來彌合患者需求與現有醫療服務提供者之間日益擴大的差距。根據美國精神健康協會於2025年10月發布的《2025年美國精神健康報告》，到2024年，23.40%的美國成年人將患有精神疾病，這意味著龐大的患者群體需要持續的遠距支持。這種日益成長的負擔正在直接加速虛擬醫療技術融入標準臨床實踐。美國醫學會於2025年12月報告稱，到2024年，71.4%的醫生使用遠端醫療平台進行病患管理，這表明在這一關鍵需求的驅動下，市場正在迅速擴張。同時，人工智慧 (AI) 和機器學習的進步正顯著改變著新興心理健康設備的有效性和普及程度，推動工具從被動監測轉向主動臨床支援。新的演算法能夠分析複雜的行為數據，提供即時診斷見解，從而顯著提升了先前對數位化解決方案持謹慎態度的心理健康專業人員的價值提案。這些技術的成熟正在為臨床工作流程帶來重大變革。根據美國心理學會於 2025 年 12 月開展的“2025 年從業者脈搏調查”，預計到 2025 年底，心理學家對 AI 工具的採用率將飆升至 56%，與往年相比顯著成長。這些創新不僅減輕了行政負擔，還使醫療保健專業人員能夠大規模地提供個人化、數據驅動的干涉措施，從而鞏固了 AI 在現代心理健康基礎設施中的基礎性作用。

市場挑戰

嚴格的法規環境和日益成長的資料隱私擔憂是新興的全球心理健康設備和平台市場發展的主要障礙。開發醫療設備軟體（SaMD）需要遵守複雜的合規標準，迫使企業投入大量資源用於法律和安全基礎設施建設。對於擁有創新技術但可能缺乏資源來應對漫長認證流程的創新者而言，這種經濟負擔尤其沉重。因此，新型數位療法的上市時間顯著延長，減緩了整體創新步伐。此外，醫療服務提供者在沒有絕對安全保障的情況下不願意整合這些平台，嚴重限制了市場滲透率。心理健康專業人員如果意識到資料外洩的風險，使用數位介入的意願就會降低。美國醫學會（AMA）的一項調查顯示，87%的醫生強調，到2025年，資料隱私保障將是採用人工智慧驅動的醫療工具的關鍵因素。這表明，如果沒有強力的安全措施，僅靠臨床療效是不夠的。因此，市場成長受到需要透過廣泛且成本高昂的合規檢驗來贏得醫療專業人員信任的限制。

市場趨勢

將虛擬實境（VR）技術引入暴露療法正在革新臨床治療方案，使醫療專業人員能夠為患有創傷後壓力症候群（PTSD）、焦慮症和恐懼症的患者創建可控的身臨其境型環境。與傳統的談話療法不同，這項技術能夠幫助患者安全、循序漸進地暴露於創傷性刺激，並透過遊戲化的復健練習顯著提高患者的參與度和治療依從性。隨著醫療服務提供者認知到這種方法在提供標準化和可重複護理方面的有效性，該治療方法正迅速從實驗性試點階段走向醫療機構的廣泛應用。根據XR健康聯盟於2025年10月發布的《XR健康概覽》報告，約30%的英國國家醫療服務體系（NHS）信託機構已經實施了擴增實境（XR）解決方案來增強治療效果，這表明公共醫療系統正在大力轉向身臨其境型數位介入。數位心理健康解決方案與企業健康計畫的整合正在從根本上改變市場的產生收入模式，因為雇主正逐漸成為心理健康平台的主要商業管道。為了緩解與職業倦怠相關的生產力下降並降低長期醫療成本，企業正積極將數位療法工具融入員工福利計畫。這一趨勢強調預防性醫療保健和心理韌性訓練，將重點從治療急性症狀轉向維護員工的整體心理健康。根據商業健康集團 (Business Group on Health) 於 2025 年 5 月開展的“2025 年雇主福祉戰略調查”，全球 93% 的受訪雇主表示計劃維持或擴展與員工福祉相關的服務，這鞏固了企業作為新興心理健康技術主要資助者的地位。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：新興心理健康設備與平台的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（平台、裝置）
    • 依應用領域（壓力、焦慮、憂鬱症、躁鬱症等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美新興心理健康設備與平台市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲新興心理健康設備與平台市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區新興心理健康設備與平台市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲新興心理健康設備和平台的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲新興心理健康設備與平台市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球新興心理健康設備與平台市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Electromedical Products International, Inc
  • Ginger Group Ltd.
  • Happify Health
  • Headspace Inc.
  • Pear Therapeutics, Inc.
  • Quartet Health
  • Teladoc Health Inc.
  • Woebot Health
  • Clarigent Health
  • Feel Therapeutics Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17477

The Global Emerging Mental Health Devices and Platforms Market is projected to expand significantly, growing from USD 4.37 Billion in 2025 to USD 12.67 Billion by 2031, at a compound annual growth rate (CAGR) of 19.41%. This sector encompasses a range of innovations, including digital therapeutics, wearable sensors for biometric tracking, and AI-powered telepsychiatry software designed to provide remote psychological support and continuous assessment. Key drivers fueling this market growth are the increasing global incidence of psychological disorders and a severe scarcity of qualified mental health professionals, which collectively demand scalable digital interventions to bridge existing care gaps. These factors are further bolstered by growing regulatory backing for remote patient monitoring and a transition towards value-based care models that prioritize accessibility and early intervention over traditional in-person therapies.However, the market faces considerable obstacles, primarily stemming from data privacy concerns and the intricate regulatory environment governing software as a medical device, which can impede product launches. Stringent compliance requirements related to patient data security represent a significant barrier for new developers seeking market entry. The World Health Organization reported that by 2025, tele-mental health services had expanded to over 60% of countries globally, underscoring a substantial infrastructural shift that providers must navigate alongside these complex regulatory challenges.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.37 Billion
Market Size 2031USD 12.67 Billion
CAGR 2026-203119.41%
Fastest Growing SegmentAnxiety
Largest MarketNorth America

Market Driver

The escalating global prevalence of mental health disorders serves as the primary catalyst for the market, generating an urgent need for scalable and accessible therapeutic interventions that traditional in-person care models cannot adequately provide. As instances of anxiety and depression intensify, healthcare systems are increasingly adopting digital platforms to close the widening gap between patient demand and available providers. According to the '2025 State of Mental Health in America' report by Mental Health America in October 2025, 23.40% of U.S. adults experienced a mental illness in 2024, indicating a vast patient population requiring ongoing, remote support. This growing burden has directly accelerated the integration of virtual care technologies into standard clinical practice; the American Medical Association reported in December 2025 that 71.4% of physicians used telehealth platforms in 2024 for patient management, demonstrating the market's rapid expansion driven by this critical demand.Concurrently, advancements in Artificial Intelligence and Machine Learning are profoundly transforming the effectiveness and adoption of emerging mental health devices by evolving tools from mere passive monitoring to active clinical assistance. New algorithms are capable of analyzing intricate behavioral data to deliver real-time diagnostic insights, substantially enhancing the value proposition for mental health professionals who may have previously been hesitant to embrace digital solutions. This technological maturity is instigating a significant shift in clinical workflows; the American Psychological Association's '2025 Practitioner Pulse Survey' in December 2025 revealed that AI tool adoption among psychologists surged to 56% by late 2025, a marked increase from prior years. These innovations not only reduce administrative burdens but also empower providers to deliver personalized, data-driven interventions at scale, thereby cementing AI's foundational role in modern mental health infrastructure.

Market Challenge

The stringent regulatory environment and escalating data privacy concerns pose a significant impediment to the growth of the Global Emerging Mental Health Devices and Platforms Market. Developing software as a medical device (SaMD) necessitates navigating complex compliance standards, compelling companies to allocate substantial resources to legal and security infrastructure. This financial strain is particularly burdensome for innovators who, despite possessing valuable technology, may lack the resources to endure lengthy certification processes. Consequently, the time-to-market for new digital therapeutics is considerably prolonged, thereby decelerating the overall pace of innovation.Furthermore, reluctance among providers to integrate these platforms without absolute guarantees of security severely restricts market penetration. When mental health professionals perceive a risk of data breaches, their willingness to utilize digital interventions decreases. According to the American Medical Association in 2025, 87% of physicians emphasized that data privacy assurances were a critical factor for their adoption of AI-driven healthcare tools. This highlights that clinical effectiveness alone is insufficient without rigorous security measures. As a result, market growth is constrained by the imperative to earn practitioner trust through extensive and costly compliance verification.

Market Trends

The integration of Virtual Reality (VR) for Exposure Therapy is revolutionizing clinical treatment protocols by enabling practitioners to create controlled, immersive environments for patients struggling with PTSD, anxiety, and phobias. Unlike traditional talk therapy, this technology facilitates safe, gradual exposure to traumatic stimuli, significantly boosting patient engagement and retention rates through gamified rehabilitation exercises. This modality is rapidly transitioning from experimental pilots to widespread institutional adoption as healthcare providers acknowledge its effectiveness in delivering standardized, replicable care. The 'XR Health Landscape' report by the XR Health Alliance in October 2025 indicated that approximately 30% of NHS Trusts have already implemented extended reality solutions to enhance therapeutic delivery, signaling a robust shift towards immersive digital interventions within public health systems.The convergence of digital mental health solutions with corporate wellness programs is establishing employers as a key commercial channel for mental health platforms, fundamentally altering the market's revenue generation mechanisms. Organizations are proactively integrating digital therapeutic tools into employee benefit schemes to mitigate productivity losses associated with burnout and to reduce long-term healthcare expenditures. This trend emphasizes preventative care and resilience training, shifting the focus from treating acute conditions to maintaining continuous psychological well-being across the workforce. The '2025 Employer Well-being Strategy Survey' by the Business Group on Health in May 2025 found that 93% of surveyed global employers affirmed their plans to maintain or expand their well-being offerings, solidifying the corporate sector's role as a critical financier of emerging mental health technologies.

Key Market Players

  • Electromedical Products International, Inc
  • Ginger Group Ltd.
  • Happify Health
  • Headspace Inc.
  • Pear Therapeutics, Inc.
  • Quartet Health
  • Teladoc Health Inc.
  • Woebot Health
  • Clarigent Health
  • Feel Therapeutics Inc.

Report Scope

In this report, the Global Emerging Mental Health Devices and Platforms Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Emerging Mental Health Devices and Platforms Market, By Type

  • Platforms
  • Devices

Emerging Mental Health Devices and Platforms Market, By Application

  • Stress
  • Anxiety
  • Depression
  • Bipolar Disorder
  • Others

Emerging Mental Health Devices and Platforms Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Emerging Mental Health Devices and Platforms Market.

Available Customizations:

Global Emerging Mental Health Devices and Platforms Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Emerging Mental Health Devices and Platforms Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Platforms, Devices)
    • 5.2.2. By Application (Stress, Anxiety, Depression, Bipolar Disorder, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Emerging Mental Health Devices and Platforms Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Emerging Mental Health Devices and Platforms Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Emerging Mental Health Devices and Platforms Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Emerging Mental Health Devices and Platforms Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Emerging Mental Health Devices and Platforms Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Emerging Mental Health Devices and Platforms Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Emerging Mental Health Devices and Platforms Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Emerging Mental Health Devices and Platforms Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Emerging Mental Health Devices and Platforms Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Emerging Mental Health Devices and Platforms Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Emerging Mental Health Devices and Platforms Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Emerging Mental Health Devices and Platforms Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Emerging Mental Health Devices and Platforms Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Emerging Mental Health Devices and Platforms Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Emerging Mental Health Devices and Platforms Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Emerging Mental Health Devices and Platforms Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Emerging Mental Health Devices and Platforms Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Emerging Mental Health Devices and Platforms Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Emerging Mental Health Devices and Platforms Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Emerging Mental Health Devices and Platforms Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Emerging Mental Health Devices and Platforms Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Emerging Mental Health Devices and Platforms Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Emerging Mental Health Devices and Platforms Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Emerging Mental Health Devices and Platforms Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Emerging Mental Health Devices and Platforms Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Electromedical Products International, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ginger Group Ltd.
  • 15.3. Happify Health
  • 15.4. Headspace Inc.
  • 15.5. Pear Therapeutics, Inc.
  • 15.6. Quartet Health
  • 15.7. Teladoc Health Inc.
  • 15.8. Woebot Health
  • 15.9. Clarigent Health
  • 15.10. Feel Therapeutics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer